✦ LIBER ✦

A multicenter phase I–II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer

✍ Scribed by Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, P.; Politaki, E.; Malamos, N.; Polyzos, A.; Kakolyris, S.; Georgoulias, V.; Mavroudis, D.

Book ID: 121945621
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 348 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2013.08.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly epirubicin plus docetaxel as firs

Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer

✍ Gamucci, T; D'Ottavio, A M; Magnolfi, E; Barduagni, M; Vaccaro, A; Sperduti, I; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Multicenter phase II study of trastuzuma

Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

Biomarker results from the AVADO phase 3

Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer

✍ Miles, D W; de Haas, S L; Dirix, L Y; Romieu, G; Chan, A; Pivot, X; Tomczak, P; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

Multicentric phase II trial of gemcitabi

Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

A Phase II Trial of Docetaxel With Bevac

A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)

✍ Sara A. Hurvitz; Heather J. Allen; Rebecca L. Moroose; David Chan; Christopher H 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 598 KB

Phase II Multicenter Study of Docetaxel

Phase II Multicenter Study of Docetaxel and Bevacizumab With or Without Trastuzumab as First-Line Treatment for Patients With Metastatic Breast Cancer

✍ Schwartzberg, Lee S.; Badarinath, Suprith; Keaton, Mark R.; Childs, Barrett H. 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 451 KB